Institut Català d' Oncologia L'Hospitalet (ICO)

Barcelona

0 studies enrolling now · 1 studies all time

What they study most

HER2-positive Breast Cancer

Studies at this site

• PHESGO Maintenance After T-DXd Short Induction for HER2+ Unresectable Locally Recurrent or Metastatic Breast Cancer — Running, not enrolling